SREBF2 and metabolic dysfunction-associated steatotic liver disease: In addition, it was noted that SREBF-2 polymorphism has a significant impact on lipid and glucose metabolism and liver histology in biopsy-proven NAFLD patients and predisposes healthy individuals to develop non-obese NAFLD [77].